Kirsten Flowers - Net Worth and Insider Trading

Kirsten Flowers Net Worth

The estimated net worth of Kirsten Flowers is at least $382,637 dollars as of 2024-11-13. Kirsten Flowers is the CCO & Chief Strategy Officer of Kura Oncology Inc and owns about 20,605 shares of Kura Oncology Inc (KURA) stock worth over $382,635. Kirsten Flowers is also the Director of Comera Life Sciences Holdings Inc and owns about 22,199 shares of Comera Life Sciences Holdings Inc (CMRA) stock worth over $2. Details can be seen in Kirsten Flowers's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Kirsten Flowers has not made any transactions after 2023-01-27 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Kirsten Flowers

To

Kirsten Flowers Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Kirsten Flowers owns 3 companies in total, including Kura Oncology Inc (KURA) , PMV Pharmaceuticals Inc (PMVP) , and Comera Life Sciences Holdings Inc (CMRA) .

Click here to see the complete history of Kirsten Flowers’s form 4 insider trades.

Insider Ownership Summary of Kirsten Flowers

Ticker Comapny Transaction Date Type of Owner
KURA Kura Oncology Inc 2023-01-27 Chief Commercial Officer
PMVP PMV Pharmaceuticals Inc 2022-01-05 director
CMRA Comera Life Sciences Holdings Inc 2023-01-04 director

Kirsten Flowers Latest Holdings Summary

Kirsten Flowers currently owns a total of 2 stocks. Among these stocks, Kirsten Flowers owns 20,605 shares of Kura Oncology Inc (KURA) as of January 27, 2023, with a value of $382,635 and a weighting of 100%. Kirsten Flowers also owns 22,199 shares of Comera Life Sciences Holdings Inc (CMRA) as of January 4, 2023, with a value of $2 and a weighting of 0%.

Latest Holdings of Kirsten Flowers

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
KURA Kura Oncology Inc 2023-01-27 20,605 18.57 382,635
CMRA Comera Life Sciences Holdings Inc 2023-01-04 22,199 0.00 2

Holding Weightings of Kirsten Flowers


Kirsten Flowers Form 4 Trading Tracker

According to the SEC Form 4 filings, Kirsten Flowers has made a total of 1 transactions in Kura Oncology Inc (KURA) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Kura Oncology Inc is the sale of 1,906 shares on January 27, 2023, which brought Kirsten Flowers around $26,474.

According to the SEC Form 4 filings, Kirsten Flowers has made a total of 1 transactions in Comera Life Sciences Holdings Inc (CMRA) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Comera Life Sciences Holdings Inc is the acquisition of 13,513 shares on January 4, 2023, which cost Kirsten Flowers around $16,621.

Insider Trading History of Kirsten Flowers

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Kirsten Flowers Trading Performance

GuruFocus tracks the stock performance after each of Kirsten Flowers's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Kirsten Flowers is -31.78%. GuruFocus also compares Kirsten Flowers's trading performance to market benchmark return within the same time period. The performance of stocks bought by Kirsten Flowers within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Kirsten Flowers's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Kirsten Flowers

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 2.33 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -5.03 LIMIT LIMIT LIMIT LIMIT LIMIT

Kirsten Flowers Ownership Network

Ownership Network List of Kirsten Flowers

No Data

Ownership Network Relation of Kirsten Flowers

Insider Network Chart

Kirsten Flowers Owned Company Details

What does Kura Oncology Inc do?

Who are the key executives at Kura Oncology Inc?

Kirsten Flowers is the Chief Commercial Officer of Kura Oncology Inc. Other key executives at Kura Oncology Inc include Chief Legal Officer Teresa Brophy Bair , Chief Medical Officer Stephen Dale , and SVP & Finance & Accounting Thomas James Doyle .

Kura Oncology Inc (KURA) Insider Trades Summary

Over the past 18 months, Kirsten Flowers made no insider transaction in Kura Oncology Inc (KURA). Other recent insider transactions involving Kura Oncology Inc (KURA) include a net sale of 4,668 shares made by Teresa Brophy Bair , a net sale of 91,052 shares made by Troy Edward Wilson , and a net purchase of 50,000 shares made by Thomas Malley .

In summary, during the past 3 months, insiders sold 0 shares of Kura Oncology Inc (KURA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 111,517 shares of Kura Oncology Inc (KURA) were sold and 50,000 shares were bought by its insiders, resulting in a net sale of 61,517 shares.

Kura Oncology Inc (KURA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Kura Oncology Inc Insider Transactions

No Available Data

Kirsten Flowers Mailing Address

Above is the net worth, insider trading, and ownership report for Kirsten Flowers. You might contact Kirsten Flowers via mailing address: C/o Kura Oncology, Inc., 12730 High Bluff Drive, Suite 400, San Diego Ca 92130.